Emmanuel Di Paolo

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

Alemnew F. Dagnew, Osman İlhan, Won Sik Lee et al. · The Lancet Infectious Diseases · 2019 · 242 citations

Vaccination, Vaccine Safety, Vaccinology +11

Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial

Peter Vink, Josep Ramón, Ana Sánchez‐Fructuoso et al. · Clinical Infectious Diseases · 2019 · 185 citations · Full text

Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in patients with solid tumors, vaccinated before or during chemotherapy: A randomized trial

Peter Vink, Ignacio Delgado Mingorance, C. Maximiano Alonso et al. · Cancer · 2019 · 112 citations · Full text

The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70

Céline Boutry, Andrew Hastie, Javier Díez‐Domingo et al. · Clinical Infectious Diseases · 2021 · 90 citations · Full text

Transcriptional regulation, occurrence and putative role of the Pht family of Streptococcus pneumoniae

Stéphane Rioux, Cécile Neyt, Emmanuel Di Paolo et al. · Microbiology · 2010 · 75 citations

Transcriptional Regulation, Streptococcus Pneumoniae, Poor Culture Medium +15